Press Releases

Cardiac Dimensions Announces Two New Meta-Analysis Publications Showing Statistically Significant and Clinically Meaningful Benefits to Heart Failure Patients Suffering from Functional Mitral Regurgitation April 7, 2021

Cardiac Dimensions Welcomes Robert White to its Board of Directors April 6, 2021

Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of the Carillon Mitral Contour System® September 29, 2020

Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation September 2, 2020

Additional Press Releases

Cardiac Dimensions Hires Gretchen Gary as Vice President of Global Therapy Development March 6, 2020

New Data Confirms Cardiac Dimensions’ Carillon System Shows Favorable Long-Term Survival Rate in Patients with Functional Mitral Regurgitation February 25, 2020

REDUCE FMR Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure September 12, 2019

Cardiac Dimensions Reaches 1,000 Implants of Carillon System, a Minimally Invasive Treatment for Functional Mitral Regurgitation July 1, 2019

New Data Shows The Carillon Mitral Contour System^® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting June 13, 2019

New Data Confirms Cardiac Dimensions’ Carillon System Provides Acute Hemodynamic Efficacy in Patients with Functional Mitral Regurgitation April 26, 2019

Cardiac Dimensions Appoints Carmelo Mastrandrea as Vice President of Sales January 15, 2019

Cardiac Dimensions Announces DRG Reimbursement Code for Carillon Mitral Contour System^® in Germany October 18, 2018

In Randomized Blinded Study, the Carillon Mitral Contour System Catheter-Based Treatment Meets Endpoint for Reduction in Regurgitant Volume September 24, 2018

Cardiac Dimensions Announces Late-Breaking Data to be Presented at The Transcatheter Cardiovascular Therapeutics Conference (TCT) 2018 September 20, 2018

News & Events

Cardiac Dimensions @Carillon_CDI

An est. 26 mil. people suffer from #heartfailure worldwide, and the number is growing rapidly. Approx. 70% of those with heart failure have FMR. The #CarillonSystem® is a minimally-invasive treatment option, uniquely designed to treat FMR. Learn more: https://t.co/ZNbF2R4YtJ https://t.co/NEBBFyuLR7

View on Twitter

Cardiac Dimensions @Carillon_CDI

Congrats to the St. Josefs-Hospital Wiesbaden team on the first #remoteproctoring cases with the Carillon Mitral Contour System®. We're proud to partner with this team to help them offer the best treatment options for patients suffering from FMR.

#CardioTwitter https://t.co/03g7jCBZ7t

View on Twitter

Cardiac Dimensions @Carillon_CDI

Learn more about our two new publications in the @ESC_Journals. They were conducted from 3 prospective, core lab reviewed, CEC/DSMB adjudicated and 3rd party monitored #clinicalstudies which enrolled 209 HF patients with reduced ejection fraction and #FMR. https://t.co/70j4EV7Rie https://t.co/kSXoC7PjzD

View on Twitter